◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Guardian Pharmacy Services, Inc.

CIK: 1802255 SIC: 5912
$1.45B
Revenue
$49.22M
Net Income
20.21%
Gross Margin
5.02%
Op. Margin
$155.29M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 2 of 2 annual reports available (2024 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
+ Total Revenue $1.45B $1.45B $1.23B
Revenue Growth % 0.0% 17.9% nan%
Cost of Revenue $1.16B $1.16B $984.04M
+ Gross Profit $292.72M $292.72M $244.37M
Gross Margin % 20.2% 20.2% 19.9%
Selling General & Admin $220.02M $220.02M $307.29M
+ Operating Income $72.70M $72.70M $-62.92M
Operating Margin % 5.0% 5.0% -5.1%
Interest Expense $1.17M $650.00K $3.12M
Other Income/Expense $1.39M $1.39M $-279.00K
Income Before Tax $73.42M $73.42M $-66.48M
Income Tax Expense $24.46M $24.46M $4.56M
+ Net Income $49.22M $49.22M $-110.05M
Net Margin % 3.4% 3.4% -9.0%
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
Cash & Cash Equivalents $65.62M $4.66M
Accounts Receivable $101.61M $97.15M
Inventory $43.36M $40.55M
Other Current Assets $11.04M $9.62M
Total Current Assets $221.63M $151.99M
Property Plant & Equipment $55.52M $49.88M
Goodwill $79.74M $69.30M
Intangible Assets $18.48M $14.91M
Other Non-current Assets $436.00K $383.00K
Total Assets $412.66M $320.81M
Accounts Payable $116.21M $102.42M
Other Current Liabilities $22.30M $20.43M
Total Current Liabilities $160.70M $144.12M
Long-term Debt - -
Other Non-current Liabilities $4.04M $3.42M
Total Liabilities $194.73M $170.83M
Retained Earnings $66.34M $17.12M
Total Stockholders Equity $217.92M $149.98M
Total Liabilities & Equity $412.66M $320.81M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
Net Income $49.22M $49.22M $-110.05M
Depreciation & Amortization $38.36M $22.34M $19.77M
Stock-based Compensation $26.23M $13.85M $131.49M
Deferred Income Tax - $3.07M $701.00K
Change in Receivables $7.97M $8.55M $25.48M
Change in Inventory $6.23M $877.00K $1.15M
Change in Payables $22.02M $16.40M $13.23M
Operating Cash Flow $155.29M $100.25M $57.96M
Capital Expenditure - $13.42M $14.71M
Investing Cash Flow $-56.32M $-32.23M $-30.41M
Stock Issued - $29.04M $119.78M
Stock Repurchased - - $55.18M
Financing Cash Flow $-14.52M $-7.07M $-23.64M
Net Change in Cash $84.45M $60.96M $3.91M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $377.43M - $1.05B -
Cost of Revenue $302.71M - $843.85M -
Gross Profit $74.72M - $207.22M -
Selling General & Admin $58.37M - $165.28M -
Operating Income $16.35M - $41.94M -
Interest Expense $160.00K - $510.00K -
Other Income/Expense $437.00K - $887.00K -
Income Before Tax $16.63M - $42.32M -
Income Tax Expense $7.04M - $14.63M -
Net Income $9.82M $15.85M $28.30M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $36.49M $4.66M
Accounts Receivable $106.19M $97.15M
Inventory $47.86M $40.55M
Other Current Assets $7.75M $9.62M
Total Current Assets $198.28M $151.99M
Property Plant & Equipment $56.12M $49.88M
Goodwill $79.57M $69.30M
Intangible Assets $18.91M $14.91M
Other Non-current Assets $387.00K $383.00K
Total Assets $390.04M $320.81M
Accounts Payable $121.67M $102.42M
Other Current Liabilities $17.61M $20.43M
Total Current Liabilities $161.95M $144.12M
Other Non-current Liabilities $5.22M $3.42M
Total Liabilities $194.54M $170.83M
Retained Earnings $45.42M $17.12M
Total Stockholders Equity $195.50M $149.98M
Total Liabilities & Equity $390.04M $320.81M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $9.82M $15.85M $28.30M -
Depreciation & Amortization - - $16.59M -
Stock-based Compensation - - $12.77M -
Change in Receivables - - $11.59M -
Change in Inventory - - $5.67M -
Change in Payables - - $21.15M -
Operating Cash Flow - - $65.66M -
Capital Expenditure - - $12.92M -
Investing Cash Flow - - $-27.52M -
Stock Issued - - $29.04M -
Financing Cash Flow - - $-6.31M -
Net Change in Cash - - $31.83M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...